FDA Approves Oral Dosage Form for Oxibendazole Suspension in Horses

Summary

The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. for revised food safety labeling of oxibendazole suspension administered orally to horses as an antiparasitic treatment.